MGUS(未確定の意義を持つ単クローン性ガンマグロブリン血症):傍観者か加害者か - その重要性と課題の解明
Malini Surapaneni1, Jacob Edmisson1, Attaya Suvannasankha2
1Indiana University Melvin and Bren Simon Comprehensive Cancer Center, 535 Barnhill Dr, Indianapolis, IN 46202, United States of America.
Abstract:
Monoclonal gammopathy of undetermined significance (MGUS) represents a premalignant clinical state with an evolving footprint beyond its established role as a precursor to multiple myeloma. This review is intended for hematologists, oncologists, and translational investigators involved in MGUS risk stratification and prevention research and confronts four unresolved controversies shaping modern MGUS management: (1) The debate surrounding population screening-weighing potential benefits against economic/psychological burdens; (2) Limitations of current risk-stratification models and the promise of dynamic genomic tools; (3) The contentious pathogenic role of MGUS in non-malignant conditions versus its frequent bystander status; and (4) The paradigm-shifting question of early intervention to prevent malignancy. We synthesize emerging evidence suggesting that while MGUS presents unique opportunities for myeloma prevention, significant knowledge gaps persist in risk prediction, disease biology, and therapeutic strategy. Future progress hinges on defining the right patient, right time, and right intervention through advanced biomarker discovery and carefully designed clinical trials.
関連する概念動画
Bystander Effect
Statistical Significance
Significance of Center of Mass
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Significance Testing: Overview


